{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:24:26Z","timestamp":1791015866227,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11220-x","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:49:27Z","timestamp":1750420167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug resistance profile of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients and their household contacts in central Ethiopia"],"prefix":"10.1186","volume":"25","author":[{"given":"Getachew","family":"Seid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayinalem","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getu","family":"Diriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betselot","family":"Zerihun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemechu","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon H.","family":"Mariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balako","family":"Gumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"11220_CR1","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2023; WHO: Geneva, Switzerland. 2024. Available online: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024"},{"issue":"1","key":"11220_CR2","first-page":"l","volume":"5","author":"G Delogu","year":"2013","unstructured":"Delogu G, Sali M, Fadda G. The biology of mycobacterium tuberculosis infection. Mediterranean J Hematol Infect Dis. 2013;5(1):l.","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"1","key":"11220_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12879-019-3870-1","volume":"19","author":"YA Melsew","year":"2019","unstructured":"Melsew YA, Gambhir M, Cheng AC, McBryde ES, Denholm JT, Tay EL, et al. The role of super-spreading events in Mycobacterium tuberculosis transmission: evidence from contact tracing. BMC Infect Dis. 2019;19(1):244.","journal-title":"BMC Infect Dis"},{"key":"11220_CR4","doi-asserted-by":"crossref","unstructured":"Brooks-Pollock E, Danon L, Korthals Altes H, Davidson JA, Pollock AMT, van Soolingen D, et al. A model of tuberculosis clustering in low-incidence countries reveals more transmission in the United Kingdom than the Netherlands between 2010 and 2015. PLoS Comput Biol. 2020;16:e1007687.","DOI":"10.1371\/journal.pcbi.1007687"},{"key":"11220_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.5588\/ijtld.17.0061","volume":"21","author":"CA Rodriguez","year":"2017","unstructured":"Rodriguez CA, Sasse S, Yuengling KA, Azzawi S, Becerra MC, Yuen CM. A systematic review of National policies for the management of persons exposed to tuberculosis. Int J Tuberc Lung Dis. 2017;21:935\u201340.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11220_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/1471-2334-13-571","volume":"13","author":"IG Sia","year":"2013","unstructured":"Sia IG, Buckwalter SP, Doerr KA, Lugos S, Kramer R, Orillaza-Chi R, et al. Genotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the Philippines. BMC Infect Dis. 2013;13:571.","journal-title":"BMC Infect Dis"},{"key":"11220_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/cid\/ciz235","volume":"70","author":"A Gupta","year":"2019","unstructured":"Gupta A, Swindells S, Kim S, Hughes MD, Naini L, Wu X, et al. Feasibility of identifying household contacts of rifampin- and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease. Clin Infect Dis. 2019;70:425\u201335.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"11220_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/cid\/ciaa613","volume":"73","author":"SS Chiang","year":"2021","unstructured":"Chiang SS, Brooks MB, Jenkins HE, Rubenstein D, Seddon JA, van de Water BJ, et al. Concordance of Drug-resistance profiles between persons with Drug-resistant tuberculosis and their household contacts: A systematic review and Meta-analysis. Clin Infect Dis. 2021;73(2):250\u201363.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11220_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/antibiotics12030598","volume":"12","author":"S Soedarsono","year":"2023","unstructured":"Soedarsono S, Mertaniasih NM, Kusmiati T, Permatasari A, Ilahi WK, Anggraeni AT. Characteristics of previous tuberculosis treatment history in patients with treatment failure and the impact on acquired Drug-Resistant tuberculosis. Antibiot (Basel). 2023;12(3):598.","journal-title":"Antibiot (Basel)"},{"key":"11220_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2023.04.392","volume":"132","author":"G Diriba","year":"2023","unstructured":"Diriba G, Alemu A, Yenew B, Tola HH, Gamtesa DF, Mollalign H, et al. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Int J Infect Dis. 2023;132:50\u201363.","journal-title":"Int J Infect Dis"},{"key":"11220_CR11","unstructured":"Ministry of Health. Guidelines for Clinical and Programmatic Management of TB, TB\/HIV, DR-TB and Leprosy in Ethiopia. Addis Ababa, Ethiopia 2021 7th edition."},{"key":"11220_CR12","unstructured":"Ministry of Health. National Tuberculosis leprosy and other lung disease bi-annual review report 2025. Addis Ababa,Ethiopia."},{"key":"11220_CR13","doi-asserted-by":"publisher","first-page":"e02314","DOI":"10.1128\/JCM.02314-20","volume":"59","author":"Y Cao","year":"2021","unstructured":"Cao Y, Parmar H, Guar R, Lieu D, Raghunath S, Via N, et al. Xpert MTB\/XDR: a 10-color reflex assay suitable for point-of-care settings to detect isoniazid, fluoroquinolone, and second-line-injectable-drug resistance directly from mycobacterium tuberculosis-positive sputum. J Clin Microbiol. 2021;59:e02314\u201320.","journal-title":"J Clin Microbiol"},{"key":"11220_CR14","unstructured":"CHAPTLE, Introductory Biostatics. 2003 by John Wiley & Sons, Inc. ISBN 0-471-41816-1."},{"key":"11220_CR15","doi-asserted-by":"crossref","unstructured":"Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of Mycobacterium tuberculosis among new smear positive pulmonary Tuberculosis patients in Eastern Ethiopia. Tuberculosis Res Treat. 2014:2014;753492.","DOI":"10.1155\/2014\/753492"},{"key":"11220_CR16","unstructured":"Xpert MTBRIF. Ultra assay ENGLISH package insert. 2020;302\u20133514 Rev A. n.d."},{"key":"11220_CR17","unstructured":"Xpert MTB-XDRENGLISH. Package Insert 302\u20133514 Rev A. URL: https:\/\/cepheid.widen.net\/s\/cwc24p8lcl Accessed on 06th october 2024."},{"issue":"6","key":"11220_CR18","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/JCM.02501-08","volume":"47","author":"B Springer","year":"2009","unstructured":"Springer B, Lucke K, Calligaris-Maibach R, Ritter C, B\u00f6ttger EC. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and epicenter instrumentation. J Clin Microbiol. 2009;47(6):1773\u201380.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"11220_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1128\/JCM.05188-11","volume":"50","author":"S Siddiqi","year":"2012","unstructured":"Siddiqi S, Ahmed A, Asif S. Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study. J Clin Microbiol. 2012;50(2):435\u201340.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"11220_CR20","doi-asserted-by":"publisher","first-page":"e0303460","DOI":"10.1371\/journal.pone.0303460","volume":"19","author":"B Yenew","year":"2024","unstructured":"Yenew B, Kebede A, Alemu A, Diriba G, Mehammed Z, Amare M, et al. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in ethiopia: A multicenter study. PLoS ONE. 2024;19(5):e0303460.","journal-title":"PLoS ONE"},{"issue":"1","key":"11220_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/antibiotics12010166","volume":"12","author":"N Monde","year":"2023","unstructured":"Monde N, Munyeme M, Chongwe G, Wensman JJ, Zulu M, Siziya S, et al. First and Second-Line Anti-Tuberculosis Drug-Resistance patterns in pulmonary tuberculosis patients in Zambia. Antibiot (Basel). 2023;12(1):166.","journal-title":"Antibiot (Basel)"},{"key":"11220_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4236\/jtr.2017.54022","volume":"5","author":"SA Yonge","year":"2017","unstructured":"Yonge SA, Otieno MF, Sharma RR, Nteka SS. Drug susceptibility patterns of Mycobacterium tuberculosis isolates from Tuberculosis patients in coastal Kenya. J Tuberc Res. 2017;5:201\u201319.","journal-title":"J Tuberc Res"},{"issue":"1","key":"11220_CR23","doi-asserted-by":"publisher","first-page":"e0245687","DOI":"10.1371\/journal.pone.0245687","volume":"16","author":"B Dagne","year":"2021","unstructured":"Dagne B, Desta K, Fekade R, Amare M, Tadesse M, Diriba G, et al. The epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: evidence from selected TB treatment initiating centers in Ethiopia. PLoS ONE. 2021;16(1):e0245687.","journal-title":"PLoS ONE"},{"issue":"1","key":"11220_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40249-019-0554-4","volume":"8","author":"G Diriba","year":"2019","unstructured":"Diriba G, Kebede A, Tola HH, Alemu A, Tadesse M, Tesfaye E, et al. Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia. Infect Dis Poverty. 2019;8(1):54.","journal-title":"Infect Dis Poverty"},{"key":"11220_CR25","first-page":"1","volume":"3","author":"NG Uzoewulu","year":"2014","unstructured":"Uzoewulu NG, Ibeh IN, Lawson L, Goyal M, Umenyonu N, Ofiaeli RO, Okonkwo R. Drug resistant Mycobacterium tuberculosis in tertiary hospital South east, Nigeria. J Med Microb Diagn. 2014;3:1.","journal-title":"J Med Microb Diagn"},{"key":"11220_CR26","doi-asserted-by":"publisher","first-page":"e10826","DOI":"10.7717\/peerj.10826","volume":"9","author":"A Saifullah","year":"2021","unstructured":"Saifullah A, Mallhi TH, Khan YH, Iqbal MS, Alotaibi NH, Alzarea AI, Rasheed M. Evaluation of risk factors associated with the development of MDR- and XDR-TB in a tertiary care hospital: a retrospective cohort study. PeerJ. 2021;9:e10826.","journal-title":"PeerJ"},{"issue":"11","key":"11220_CR27","doi-asserted-by":"publisher","first-page":"e031663","DOI":"10.1136\/bmjopen-2019-031663","volume":"9","author":"NR Mvelase","year":"2019","unstructured":"Mvelase NR, Balakrishna Y, Lutchminarain K, Mlisana K. Evolving rifampicin and Isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis. BMJ Open. 2019;9(11):e031663.","journal-title":"BMJ Open"},{"key":"11220_CR28","doi-asserted-by":"publisher","first-page":"e1003023","DOI":"10.1371\/journal.pmed.1003023","volume":"17","author":"G Sulis","year":"2020","unstructured":"Sulis G, Pai M. Isoniazid-resistant tuberculosis: A problem we can no longer ignore. PLoS Med. 2020;17:e1003023.","journal-title":"PLoS Med"},{"key":"11220_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1440-1843.2010.01738.x","volume":"15","author":"C-Y Chiang","year":"2010","unstructured":"Chiang C-Y, Centis R, Migliori GB. Drug-resistant tuberculosis: past, present, future. Respirology. 2010;15:413\u201332.","journal-title":"Respirology"},{"issue":"2","key":"11220_CR30","doi-asserted-by":"publisher","first-page":"e0193083","DOI":"10.1371\/journal.pone.0193083","volume":"13","author":"M Tilahun","year":"2018","unstructured":"Tilahun M, Ameni G, Desta K, Zewude A, Yamuah L, Abebe M, et al. Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo town, central Ethiopia. PLoS ONE. 2018;13(2):e0193083.","journal-title":"PLoS ONE"},{"issue":"1","key":"11220_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3978-3","volume":"19","author":"A Alelign","year":"2019","unstructured":"Alelign A, Zewude A, Mohammed T, Tolosa S, Ameni G, Petros B. Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and Isoniazid in South Gondar zone, Northwest Ethiopia. BMC Infect Dis. 2019;19(1):1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"11220_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijmyco.2016.02.009","volume":"5","author":"M Tadesse","year":"2016","unstructured":"Tadesse M, Aragaw D, Dimah B, Efa F, Abdella K, Kebede W, et al. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. Int J Mycobacteriology. 2016;5(2):185\u201391.","journal-title":"Int J Mycobacteriology"},{"issue":"4","key":"11220_CR33","doi-asserted-by":"publisher","first-page":"e0231320","DOI":"10.1371\/journal.pone.0231320","volume":"15","author":"TA Lobie","year":"2020","unstructured":"Lobie TA, Woldeamanuel Y, Asrat D, Beyene D, Bj\u00f8r\u00e5s M, Aseffa A. Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia. PLoS ONE. 2020;15(4):e0231320.","journal-title":"PLoS ONE"},{"issue":"9","key":"11220_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5588\/ijtldopen.24.0351","volume":"1","author":"S Moe","year":"2024","unstructured":"Moe S, Azamat I, Allamuratova S, Oluya M, Khristusev A, Rekart ML, et al. Second-line drug-resistant TB and associated risk factors in karakalpakstan, Uzbekistan. IJTLD Open. 2024;1(9):391\u20137.","journal-title":"IJTLD Open"},{"issue":"1","key":"11220_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13073-022-01076-0","volume":"14","author":"V Dreyer","year":"2022","unstructured":"Dreyer V, Mandal A, Dev P, Merker M, Barilar I, Utpatel C, et al. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai metropolitan region. Genome Med. 2022;14(1):95.","journal-title":"Genome Med"},{"issue":"1","key":"11220_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13756-021-00995-8","volume":"10","author":"C Yao","year":"2021","unstructured":"Yao C, Guo H, Li Q, Zhang X, Shang Y, Li T, Wang Y, Xue Z, Wang L, Li L, Pang Y. Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition. Antimicrob Resist Infect Control. 2021;10(1):126.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"11220_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/microorganisms11020425","volume":"11","author":"I Kostyukova","year":"2023","unstructured":"Kostyukova I, Pasechnik O, Mokrousov I. Epidemiology and drug resistance patterns of Mycobacterium tuberculosis in High-Burden area in Western siberia, Russia. Microorganisms. 2023;11(2):425.","journal-title":"Microorganisms"},{"issue":"5","key":"11220_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5588\/ijtld.19.0508","volume":"24","author":"D Butov","year":"2020","unstructured":"Butov D, Lange C, Heyckendorf J, Kalmykova I, Butova T, Borovok N, et al. Multidrug-resistant tuberculosis in the Kharkiv region, Ukraine. Int J Tuberc Lung Dis. 2020;24(5):485\u201391.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"11220_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5588\/ijtld.22.0632","volume":"27","author":"D Vengurlekar","year":"2023","unstructured":"Vengurlekar D, Walker C, Mahajan R, Dalal A, Chavan V, Galindo MA, et al. Linezolid resistance in patients with drug-resistant TB. Int J Tuberc Lung Dis. 2023;27(7):567\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11220_CR40","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.2147\/IDR.S408567","volume":"16","author":"M Agonafir","year":"2023","unstructured":"Agonafir M, Belay G, Feleke A, Maningi N, Girmachew F, Reta M, Fourie PB. Profile and frequency of mutations conferring Drug-Resistant tuberculosis in the central, southeastern and Eastern Ethiopia. Infect Drug Resist. 2023;16:2953\u201361. d.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"11220_CR41","doi-asserted-by":"publisher","first-page":"e0119628","DOI":"10.1371\/journal.pone.0119628","volume":"10","author":"M Seifert","year":"2015","unstructured":"Seifert M, Catanzaro D, Catanzaro A, Rodwell TC. Genetic mutations associated with Isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS ONE. 2015;10(3):e0119628.","journal-title":"PLoS ONE"},{"key":"11220_CR42","doi-asserted-by":"crossref","unstructured":"Raznatovska OM, Moskaliuk AS, Grekova TA, Chernyshova LI, Pushnova OO, Shelestina T. I. The relevance of household contacts tracing among child contacts of patients with multidrug-resistant tuberculosis. Infusion Chemother, 2020;(1):14\u201323.","DOI":"10.32902\/2663-0338-2020-1-14-23"},{"issue":"3","key":"11220_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/cid\/cit709","volume":"58","author":"JB Parr","year":"2014","unstructured":"Parr JB, Mitnick CD, Atwood SS, Chalco K, Bayona J, Becerra MC. Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2014;58(3):392\u20135.","journal-title":"Clin Infect Dis"},{"key":"11220_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s100960050445","volume":"19","author":"JJ Furin","year":"2000","unstructured":"Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. Eur J Clin Microbiol Infect Dis. 2000;19:132\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"11220_CR45","unstructured":"Farazi A, Sofian M, Zarrinfar N, Katebi F, Hoseini SD, Keshavarz R. Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran. Caspian J Intern Med. 2013 Fall;4(4):785-9."},{"issue":"6","key":"11220_CR46","doi-asserted-by":"publisher","first-page":"e044349","DOI":"10.1136\/bmjopen-2020-044349","volume":"11","author":"NN Tao","year":"2021","unstructured":"Tao NN, Li YF, Song WM, Liu JY, Zhang QY, Xu TT, et al. Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in shandong, china, during 2004\u20132019. BMJ Open. 2021;11(6):e044349.","journal-title":"BMJ Open"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11220-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:49:30Z","timestamp":1750420170000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11220-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11220"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11220-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"806"}}